PortfoliosLab logoPortfoliosLab logo
ALHC vs. CLOV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ALHC vs. CLOV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ALHC achieves a -27.85% return, which is significantly lower than CLOV's 55.32% return.


ALHC

1D
4.47%
1M
-26.01%
YTD
-27.85%
6M
-25.39%
1Y
-7.11%
3Y*
31.13%
5Y*
-9.42%
10Y*

CLOV

1D
-2.14%
1M
37.74%
YTD
55.32%
6M
39.31%
1Y
17.74%
3Y*
60.44%
5Y*
-16.51%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ALHC vs. CLOV - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ALHC
Alignment Healthcare Holdings, LLC
-27.85%75.56%30.66%-26.79%-16.36%-18.78%
CLOV
Clover Health Investments, Corp.
55.32%-25.40%230.85%2.43%-75.01%-50.99%

Correlation

The correlation between ALHC and CLOV is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.26

Correlation (5Y)
Calculated over the trailing 5-year period

0.34

Correlation (All Time)
Calculated using the full available price history since Mar 29, 2021

0.33

Fundamentals

Market Cap

ALHC:

$3.04B

CLOV:

$1.91B

EPS

ALHC:

$0.10

CLOV:

-$0.11

PS Ratio

ALHC:

0.69

CLOV:

0.85

PB Ratio

ALHC:

14.68

CLOV:

5.62

Total Revenue (TTM)

ALHC:

$4.26B

CLOV:

$2.21B

Gross Profit (TTM)

ALHC:

$365.25M

CLOV:

$939.14M

EBITDA (TTM)

ALHC:

$66.34M

CLOV:

-$55.21M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ALHC vs. CLOV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALHC
ALHC Risk / Return Rank: 3333
Overall Rank
ALHC Sharpe Ratio Rank: 3434
Sharpe Ratio Rank
ALHC Sortino Ratio Rank: 3333
Sortino Ratio Rank
ALHC Omega Ratio Rank: 3333
Omega Ratio Rank
ALHC Calmar Ratio Rank: 3535
Calmar Ratio Rank
ALHC Martin Ratio Rank: 3232
Martin Ratio Rank

CLOV
CLOV Risk / Return Rank: 4949
Overall Rank
CLOV Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
CLOV Sortino Ratio Rank: 5050
Sortino Ratio Rank
CLOV Omega Ratio Rank: 5050
Omega Ratio Rank
CLOV Calmar Ratio Rank: 4848
Calmar Ratio Rank
CLOV Martin Ratio Rank: 4848
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALHC vs. CLOV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ALHCCLOVDifference
Sharpe ratioReturn per unit of total volatility

-0.40

Sortino ratioReturn per unit of downside risk

-0.75

Omega ratioGain probability vs. loss probability

1.02

1.11

-0.09

Calmar ratioReturn relative to maximum drawdown

-0.16

0.32

-0.48

Martin ratioReturn relative to average drawdown

-0.49

0.58

-1.07

ALHC vs. CLOV - Sharpe Ratio Comparison

The current ALHC Sharpe Ratio is -0.14, which is lower than the CLOV Sharpe Ratio of 0.26. The chart below compares the historical Sharpe Ratios of ALHC and CLOV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ALHCCLOVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.14

0.26

-0.40

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.15

-0.19

+0.04

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.06

-0.19

+0.13

Drawdowns

ALHC vs. CLOV - Drawdown Comparison

The maximum ALHC drawdown since its inception was -83.61%, smaller than the maximum CLOV drawdown of -97.19%. Use the drawdown chart below to compare losses from any high point for ALHC and CLOV.


Loading charts...

Drawdown Indicators


ALHCCLOVDifference

Max Drawdown

Largest peak-to-trough decline

-83.61%

-97.19%

+13.58%

Max Drawdown (1Y)

Largest decline over 1 year

-44.14%

-55.50%

+11.36%

Max Drawdown (3Y)

Largest decline over 3 years

-50.33%

-64.73%

+14.40%

Max Drawdown (5Y)

Largest decline over 5 years

-83.61%

-97.19%

+13.58%

Current Drawdown

Current decline from peak

-47.74%

-83.52%

+35.78%

Average Drawdown

Average peak-to-trough decline

-52.24%

-76.62%

+24.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.49%

30.50%

-16.01%

Volatility

ALHC vs. CLOV - Volatility Comparison

Alignment Healthcare Holdings, LLC (ALHC) and Clover Health Investments, Corp. (CLOV) have volatilities of 21.43% and 22.48%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ALHCCLOVDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.43%

22.48%

-1.05%

Volatility (6M)

Calculated over the trailing 6-month period

40.00%

39.42%

+0.58%

Volatility (1Y)

Calculated over the trailing 1-year period

49.31%

68.65%

-19.34%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

62.53%

88.12%

-25.59%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

62.93%

85.63%

-22.70%

Dividends

ALHC vs. CLOV - Dividend Comparison

Neither ALHC nor CLOV has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ALHC vs. CLOV - Financials Comparison

This section allows you to compare key financial metrics between Alignment Healthcare Holdings, LLC and Clover Health Investments, Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M400.00M600.00M800.00M1.00B1.20B20222023202420252026
1.24B
749.19M
(ALHC) Total Revenue
(CLOV) Total Revenue
Values in USD except per share items

ALHC vs. CLOV - Profitability Comparison

The chart below illustrates the profitability comparison between Alignment Healthcare Holdings, LLC and Clover Health Investments, Corp. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

-20.0%0.0%20.0%40.0%60.0%80.0%100.0%202220232024202520260
92.4%
Portfolio components
ALHC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Alignment Healthcare Holdings, LLC reported a gross profit of 0.00 and revenue of 1.24B. Therefore, the gross margin over that period was 0.0%.

CLOV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a gross profit of 692.13M and revenue of 749.19M. Therefore, the gross margin over that period was 92.4%.

ALHC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Alignment Healthcare Holdings, LLC reported an operating income of 15.50M and revenue of 1.24B, resulting in an operating margin of 1.3%.

CLOV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported an operating income of 27.33M and revenue of 749.19M, resulting in an operating margin of 3.7%.

ALHC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Alignment Healthcare Holdings, LLC reported a net income of 11.42M and revenue of 1.24B, resulting in a net margin of 0.9%.

CLOV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Clover Health Investments, Corp. reported a net income of 27.33M and revenue of 749.19M, resulting in a net margin of 3.7%.


Frequently Asked Questions


ALHC and CLOV have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLOV has higher volatility (22.48%) compared to ALHC (21.43%). In terms of maximum drawdown, ALHC dropped -83.61% vs CLOV's -97.19%.

CLOV currently has the higher Sharpe Ratio (0.26 vs -0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ALHC and CLOV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer